Medical Equipment

Why AED (automatic external defibrillator) is life saving machine? Why is it so important?

What is an AED (automatic external defibrillator)? An AED is a transportable electronic device that allows the heart the effective reestablishment of the heart rhythm through defibrillation. The device also make a diagnosis of the life intimidating cardiac arrhythmias of ventricular fibrillation and pulse less ventricular tachycardia which leads to cardiac arrest and heart attacks. Why AED (automatic external defibrillator) is life saving machine? Once the cardiac arrest occurs the body cells initiate to get damaged, the first organ that is affected by [...]

Celltrion’s Rituxan biosimilar wins European approval

South Korea’s Celltrion announced Wednesday that the European Medicines Agency has granted sales approval to Truxima, its biosimilar drug referencing Roche’s blockbuster lymphatic cancer drug Rituxan. Truxima is the first ever Rituxan (rituximab) biosimilar to be approved by the European drug regulator, as well as the first ever Europe-approved biosimilar monoclonal antibody used to target cancer. Biosimilars are cheaper, near replicas of living cell-based biologic drugs whose patents have expired. The recent emergence of these alternative drugs have begun to threaten [...]

How to treat postpartum mothers with Korean medicine

“Postpartum wind” is a typical condition recognized in Korea when women experience various aftereffects of giving birth, such severe chills even in hot weather, joint pain and lower back pain, among others. Unlike the common notion that “wind” means stroke in Korean, actually it covers a wide range of symptoms such as numbness, pain, paralysis and any signs that appear all of a sudden. Postpartum wind may appear later on in the mother’s life if proper care is not [...]

Korea's homegrown drug set to post record sales

Annual sales of a diabetes drug manufactured by LG Life Sciences Ltd., the pharmaceuticals unit of South Korea’s LG Group, are likely to exceed 50 billion won ($44.9 million) this year, the drug firm said Wednesday. It would mark the first time for the annual sales of a single homegrown drug to breach the 50 billion-won mark. The combined sales of Zemiglo , which was approved as the nation’s 19th new drug in 2012, and its composite drug Zemimet came to [...]

Mug-size device detects chlamydia in 30 minutes

Scientists at Johns Hopkins University in the United States have made a portable device that detects chlamydia in just 30 minutes. Called the mobiLap, it is the size of a coffee mug. Chlamydia, which can develop into pelvic inflammatory disease and damage a woman’s reproductive system, often shows no symptoms and can be hard to detect. Researchers stress the importance of early detection, saying pelvic inflammatory disease from chlamydia can cause infertility, debilitating chronic pelvic pain and ectopic pregnancies. Doctors have used [...]

Korea to buttress biological medicine, cosmetics exports

As part of efforts to boost the local biopharmaceutical industry and exports, the Ministry of Food and Drug Safety announced Tuesday that it will shorten the review process of biologics for rare and incurable diseases so they can be approved and distributed for sale overseas as quickly as possible. A biopharmaceutical, simply known as a biologic, is any medical product extracted from or manufactured with biological sources. Examples of biologics include gene therapy, allergenic products, vaccines and blood components. Currently, there [...]

S. Korean drug firms flesh out in R&D

South Korea’s major pharmaceutical companies are planning to make big investments in research and development this year to boost their competitiveness, industry sources said Thursday. Hanmi Pharmaceutical and five others are among the country’s top 10 pharmaceutical companies expected to invest 100 billion won ($82.7 million) or more this year. Hanmi, which clinched a number of megahit licensing deals last year, will be the top investor with 210 billion won, followed by Green Cross Corp. with 120 billion won and Yuhan [...]

Korean biosimilar drugs on way to global expansion

Led by Celltrion and Samsung Bioepis, South Korea’s biopharmaceutical companies are making strides in the emerging drug category of biosimilars — lower-cost replications of the world’s top-selling biologic drugs that have lost patent protection. Drawing much spotlight this week, Samsung Bioepis, Samsung Group’s biopharmaceutical affiliate, said Sunday that Benepali, its biosimilar copy of Amgen’s blockbuster rheumatoid arthritis treatment Enbrel (etanercept) has been granted sales approval in Europe. A day later, Celltrion announced that the U.S. Food and Drug Administration is scheduled [...]

Korean drugmakers have prescription for global expansion

Korean drugmakers and bio companies, buoyed by Hanmi Pharmaceutical’s strong performance last year, are seeking overseas markets, industry sources said Wednesday. Global pharmaceutical companies’ perception of Korean industries has also become far more favorable, thanks to Hanmi’s successive contracts for technology export, encouraging the latter’s advance to foreign markets, they said. Taking the lead is Chong Kun Dang, which has been conducting clinical tests for its biosimilar product of anemia remedy CKD-11101 at home, but is planning to expand the experiment [...]

Korea to speed up tech, medical regulations

The South Korean government Friday unveiled plans to ease regulations on drones and self-driving cars, paving the way for the futuristic technologies to spur related industries. The plans were given in a brief when President Park Geun-hye presided over the fourth regulatory reform ministerial meeting at Cheong Wa Dae. “Deregulation is crucial to secure our future growth engines and to revitalize the economy,” said the president, calling for parliamentary support for the passage of related bills at the National Assembly. According to [...]